Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathological Complete Response”

363 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 363 results

Not applicableStudy completedNCT06630481
What this trial is testing

Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade

Who this might be right for
Pancreatic CancerNeoadjuvant TherapyPathological Complete Response
Seoul National University Hospital 462
Not applicableStudy completedNCT00969657
What this trial is testing

Validation of a Predictive Model After Complete Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Maastricht Radiation Oncology 80
Post-approval studies (Phase 4)Study completedNCT00171899
What this trial is testing

Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 80
Not applicableLooking for participantsNCT04743102
What this trial is testing

Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer

Who this might be right for
Rectal CancerNeoadjuvant TherapyComplete Remission+1 more
Beijing Chao Yang Hospital 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT02971748
What this trial is testing

Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

Who this might be right for
Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Breast Inflammatory Carcinoma+2 more
M.D. Anderson Cancer Center 36
Not applicableStudy completedNCT02800317
What this trial is testing

RISAS Procedure in Node Positive Breast Cancer Following NAC

Who this might be right for
Breast NeoplasmNeoadjuvant TherapyAxillary Lymph Nodes+1 more
Erasmus Medical Center 248
Testing effectiveness (Phase 2)Looking for participantsNCT06927180
What this trial is testing

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Henan Cancer Hospital 180
Not applicableStudy completedNCT02233374
What this trial is testing

Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET

Who this might be right for
Rectal Neoplasms
Royal North Shore Hospital 27
Not applicableActive Not RecruitingNCT07407244
What this trial is testing

Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer

Who this might be right for
Breast Cancer
Institute of Oncology Ljubljana 268
Large-scale testing (Phase 3)Study completedNCT00760877
What this trial is testing

Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR)

Who this might be right for
CHRONIC MYELOGENOUS LEUKEMIA
Novartis Pharmaceuticals 207
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06851169
What this trial is testing

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Alone or Combined with Anlotinib Administered Prior to Surgery in Terms of Pathological Complete Response

Who this might be right for
Non Small Cell Lung Cancer
Tang-Du Hospital 58
Not applicableActive Not RecruitingNCT02386670
What this trial is testing

Prevention of Alzheimer's Disease With CR Plus tDCS in Mild Cognitive Impairment and Depression (PACt-MD)

Who this might be right for
Mild Cognitive ImpairmentMajor Depressive Disorder, Recurrent, In RemissionMajor Depressive Disorder, Single Episode, in Full Remission
Centre for Addiction and Mental Health 375
Not applicableLooking for participantsNCT05976815
What this trial is testing

Improving Response to Chemotherapy by Adding Physical Exercise in the Neoadjuvant Setting of Breast Cancer Patients

Who this might be right for
Breast Cancer
University Institute of Maia 86
Large-scale testing (Phase 3)WithdrawnNCT05474690
What this trial is testing

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Henan Cancer Hospital
Testing effectiveness (Phase 2)UnknownNCT03038256
What this trial is testing

Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial

Who this might be right for
Rectal CancerPathological Complete ResponseDisease Free Survival
Peking University People's Hospital 244
Not applicableNot Yet RecruitingNCT05629442
What this trial is testing

CtDNA and Organ Preservation/Pathologic CR in Rectal Cancer

Who this might be right for
Rectal CancerNon Metastatic Rectal Cancer
Massachusetts General Hospital 60
Not applicableLooking for participantsNCT05854823
What this trial is testing

The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University 23
Not applicableStudy completedNCT03273426
What this trial is testing

Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.

Who this might be right for
Breast Neoplasm
Seoul National University Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT06498635
What this trial is testing

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Who this might be right for
Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 306
Large-scale testing (Phase 3)Study completedNCT01197040
What this trial is testing

Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Assistance Publique - Hôpitaux de Paris 117
Next Page